Carbidopa/Levodopa Orion 25 mg/100 mg tablets: overview

What is Carbidopa/Levodopa Orion 25 mg/100 mg?

Carbidopa/Levodopa Orion 25 mg/100 mg tablets contain two active ingredients: carbidopa 25 mg and levodopa 100 mg. They are used in the management of Parkinson’s disease and related Parkinsonian syndromes.

Levodopa is converted into dopamine in the brain. Carbidopa helps levodopa work more effectively by reducing its conversion outside the brain. This combination is intended to support symptom control in a way that can be adjusted to the individual patient’s needs.

What is it used for?

The main use of this medicine is to help manage symptoms associated with Parkinson’s disease and Parkinsonian syndromes. These symptoms may include:

• Tremor
• Rigidity or stiffness
• Slowness of movement (bradykinesia)
• Postural instability

By helping with these movement-related symptoms, the medicine may support day-to-day functioning. Treatment is usually tailored to the person’s response and tolerance.

How does the combination work?

Levodopa is the component that helps increase dopamine activity in the brain. Carbidopa supports levodopa by limiting its breakdown before it reaches the brain. Together, they are used to improve the effectiveness of treatment and reduce some unwanted effects that can happen when levodopa is taken alone.

Dosage and administration

The exact dose depends on the individual and should be set by the prescribing clinician. The original content notes that treatment may begin with one tablet three times a day, but this can vary depending on symptoms, age, and response to therapy.

General points to verify with the prescription or leaflet include:

• How many tablets to take each day
• What times to take them
• Whether the tablets should be taken with or without food
• What to do if a dose is missed

Regular review is important because the dose may need adjustment over time based on benefit and tolerability.

How should the tablets be taken?

The original content states that the tablets are generally taken with water and often 30 minutes before a meal or 1–2 hours after meals for absorption. It also notes that high-protein meals may interfere with levodopa absorption.

If a patient has questions about timing with meals, the safest approach is to check the prescription label, the patient leaflet, or a pharmacist, because instructions can differ between products and individual treatment plans.

Possible side effects

Like all medicines, this combination can cause side effects. The original content lists the following as common or reported effects:

• Nausea and vomiting
• Dizziness
• Sleep disturbances
• Involuntary movements
• Hallucinations
• Confusion
• Changes in mood

Some effects may improve as the body adjusts, but persistent, severe, or unusual symptoms should be discussed with a healthcare professional.

Precautions and safety points

Before using this medicine, the original content highlights the importance of telling a healthcare professional about any relevant medical history or allergies. It specifically mentions:

• Narrow-angle glaucoma
• Previous hypersensitivity to carbidopa or levodopa
• Active peptic ulcer disease

The medicine may cause drowsiness or dizziness, so caution is needed with driving or operating machinery until the effect on the individual is known. Pregnancy and breastfeeding should also be discussed with a healthcare professional.

What to check with a doctor or pharmacist

If you are reviewing this medicine for a patient, it is useful to confirm the following from the prescription, local guidance, or the official leaflet:

• The exact dosing schedule
• Whether food timing matters for that specific patient
• How to manage missed doses
• Which side effects need urgent review
• Any interactions with other prescribed or over-the-counter medicines

This is especially important because Parkinson’s treatment is often individualized.

Reporting side effects

The original content notes that side effects should be reported to a healthcare professional, including effects not listed in the leaflet. In the UK, suspected adverse reactions can also be reported through the Yellow Card Scheme. Reporting helps improve medicine safety monitoring.

Frequently asked questions